post hoc analyses from the beta-blocker heart attack trial suggest , and are supported by the norwegian timolol study , that myocardial infarction patients older than age 60 years and those with arrhythmic and other complications not severe enough to preclude treatment benefit the most in absolute terms from beta blockers .
C0040233
timolol
C0027051
myocardial